Latest filing published 16 Feb 2023 for Newbury Pharmaceuticals AB, €49k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -20.8%Entry SEK 5.61 · Close at T+365 SEK 4.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Hedskog Equity AB: trading record in brief
Only one filing by Hedskog Equity AB is known so far (16 February 2023): an open-market purchase, €49k, in Newbury Pharmaceuticals AB. That is too little to draw conclusions. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hedskog Equity AB
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ SEK 5.50100.0% of flowAktieISIN SE0015244884FI:csv-53cb15c9a16cfdf68e51Canonical exit: 11 May 2023 (T+90)
1 of 1 declaration